Reuters: Health
AstraZeneca Plc and Merck & Co Inc said on Monday their drug to treat a form of ovarian cancer improved progression-free survival in patients tested in a late-stage study.
![]() |
submitted by /u/greyuniwave [link] [comments] |
![]() |
submitted by /u/Warjak [link] [comments] |